Cognitive Behavior Treatment of Older Adults With Generalized Anxiety Disorder in Primary Care

• Anxiety [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  

• Depression [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  
• Sleep quality [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  
• Use of alcohol [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  
• Functional and health status [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  
• Quality of life [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  
• Pain [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  
• Satisfaction with CBT and general health care [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  
• Service utilization [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  
• Use of psychotropic medications [ Time Frame: 18 months ] [ Designated as safety issue: No ]
  

Generalized Anxiety Disorder (GAD) is one of the most common anxiety disorders among older adults. Anxiety in older adults is associated with decreased physical activity, poorer self-perceptions of health, decreased life satisfaction, and increased loneliness. Because many older adults with anxiety seek assistance in a medical setting, treatment has been primarily pharmacological. There is, however, limited evidence of the effectiveness of psychotropic medications in later life. Given the potential difficulties in prescribing psychotropic medications in later life(e.g., increased adverse effects, potential drug interactions), psychosocial treatments may be important alternatives or adjuncts.

The treatment phase of this study lasts 6 months, during which patients will be randomly assigned to either cognitive behavior treatment (CBT) with an Anxiety Clinic Specialist (ACS) or Counselor or to Usual Care (UC). All participants will complete telephone assessments at baseline, 1, 2, and 3 months during the treatment phase. During the first 12 weeks, those assigned to CBT will also complete 10-12 weekly sessions, either in person or over the telephone. During the second 12 weeks, CBT patients will receive follow-up telephone booster calls, weekly for the first 4 weeks and biweekly for the last 8 weeks. During the treatment phase, UC participants will receive no treatment from study clinicians but will continue to receive their usual care from their current medical providers.

At 6 months, all participants will complete a telephone assessment. CBT patients will enter a one year follow-up period, with telephone assessments at 12 and 18 months. UC participants will be offered the option to receive brief CBT after completion of the 6 month telephone assessment. Those who choose to participate in CBT will complete telephone assessments at 9 and 12 months.